Capital Impact Advisors’s Select Medical SEM Stock Holding History

Capital Impact Advisors’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-79,314	Closed	-$1.29M	–	92
2024 Q1	$1.29M	Buy	79,314 +38,063	+92%	+$557K	1.67%	17
2023 Q4	$522K	Hold	41,251	–	–	0.69%	70
2023 Q3	$562K	Hold	41,251	–	–	0.94%	50
2023 Q2	$708K	Sell	41,251 -20,318	-33%	-$315K	0.78%	44
2023 Q1	$858K	Sell	61,569 -559	-0.9%	-$8.23K	1.05%	13
2022 Q4	$831K	Hold	62,128	–	–	0.81%	24
2022 Q3	$791K	Buy	62,128 +5,852	+10%	+$83.1K	0.79%	27
2022 Q2	$716K	Buy	56,276 +5,785	+11%	+$74.3K	0.66%	43
2022 Q1	$653K	Buy	+50,491	New	+$667K	0.47%	104
2017 Q1	–	Sell	-157,639	Closed	-$1.13M	–	216
2016 Q4	$1.13M	Hold	157,639	–	–	0.47%	85
2016 Q3	$1.15M	Hold	157,639	–	–	0.5%	67
2016 Q2	$923K	Hold	157,639	–	–	0.43%	108
2016 Q1	$1M	Buy	157,639 +30,067	+24%	+$161K	0.48%	55
2015 Q4	$819K	Hold	127,572	–	–	0.39%	99
2015 Q3	$742K	Hold	127,572	–	–	0.38%	100
2015 Q2	$1.11M	Hold	127,572	–	–	0.51%	54
2015 Q1	$1.02M	Buy	+127,572	New	+$953K	0.47%	62

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Impact Advisors's SEM Position: Q2 2024 in Review

Capital Impact Advisors sold out of Select Medical (SEM) in Q2 2024, closing a stake of 79,314 shares — an estimated $1.29M sold.

Capital Impact Advisors first reported a position in SEM in Q1 2015 and held it in 17 quarters. The position peaked at $1.29M in Q1 2024. 256 funds tracked by Wall St. Rank hold SEM as of Q2 2024.

Capital Impact Advisors reported no remaining Select Medical position as of Q2 2024 after selling out during the quarter.
Capital Impact Advisors sold 79,314 Select Medical shares in Q2 2024, an estimated $1.29M.
Capital Impact Advisors first reported a position in Select Medical in Q1 2015 and held it in 17 quarters.
Capital Impact Advisors's Select Medical position peaked at $1.29M in Q1 2024.
256 funds tracked by Wall St. Rank held Select Medical as of Q2 2024.

Based on Capital Impact Advisors's 13F filing for Q2 2024, filed 16 Aug 2024.